ARTICLE | Company News
Seattle Genetics, Astellas deal
June 13, 2011 7:00 AM UTC
Seattle Genetics exercised a 2007 option from Astellas' Agensys Inc. subsidiary to co-develop and co-commercialize ASG-22ME. Agensys submitted an IND last quarter for a Phase I trial of the antibody...